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R453[20], later in life. Interestingly, the
onset of senescence in giant dog
breeds appeared to occur at a time
at which these animals were still
growing.
The paper by Kraus et al. [12] tells
us why big dogs die young: a St
Bernard ages more rapidly following
the onset of senescence than a
Pekinese does. We now need to
focus in on potential mechanisms
driving these differences. On a more
cautionary note, dogs are rather
peculiar given that they have been
artificially selected for phenotypic
diversity, in stark contrast to more
routine model organisms primarily
selected for similarity. However,
there is no doubting that experimental
approaches leading on from the
work by Kraus et al. will complement
those studying ageing using
classical and non-classical model
organisms in the laboratory, and
under both semi-natural and
natural conditions. We suggest
that comparative approaches both
across and within species are likely to
give key insights into what
mechanisms underlie the ageing
process.
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Replacement of Disease VectorsTo fight human vector-borne diseases, first releases of sterile transgenic
mosquitoes have been performed. Someday, disease-refractory mosquitoes
will replace wild types to stop transmission. For such population replacements,
gene drive mechanisms must be established that allow local confinement and
reversibility.Ernst A. Wimmer
The fight against Malaria and
Dengue — the two major insect-borne
diseases in tropical and subtropical
areas — is threatened by the
increasingly fast evolution of
insecticide resistance in its insect
vectors. Therefore, alternative control
tools need to be included into pest
management strategies [1]. Insect
transgenesis promises to provide suchnovel tools through the establishment
of conditional reproductive sterility
or the refractoriness to disease
transmission [2,3]. In the transmission
of vector-borne diseases, the insect is
only a nuisance, but does not actually
cause the illness itself. This has led
to the long-standing hope that wild
mosquito populations could actually
be replaced by biotechnologically
engineered strains that would be
refractory to the disease causingpathogens, such as protists or
viruses [4,5], and therefore interrupt
disease transmission [3]. As the simple
replacement of a complete insect
population by a desired strain is
not feasible, strategies need to be
developed that cause population
replacement by changing the genetic
make-up of the population
through spreading the required
refractoriness-causing transgenes.
However, the transgenes providing
refractoriness to human disease
transmission are not likely to
spread through the population by
themselves. This requires effective
gene drive mechanisms that allow
for non-Mendelian inheritance and
‘selfish genes’ are thought to be some
of the best vehicles for such a gene
drive [6]. Conversely, there are
concerns on how to contain such
selfish genes and the accompanied
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Figure 1. Maternal Effect Dominant Embry-
onic Arrest (MEDEA).
(A) MEDEA as originally described in
Tribolium castaneum [17] providing a still
hypothetical maternal lethal activity (maternal
toxin) that kills all progeny not bearing the
correct Medea allele and an embryonic
rescue activity (zygotic antidote) protecting
progeny that carry the Medea allele from
the maternal lethal effect [18]. The death
(red X) of the embryos not carrying the
Medea allele causes a non-Mendelian. (B)
Synthetic MEDEA composed of maternally
expressed microRNAs against a maternally
provided but embryonic necessary mRNA
and a zygotic rescue gene, which is driven
by an early embryonic promoter and
insensitive to the microRNAs, thus providing
the necessary gene function to restore the
maternal-driven gene knock-out [19].
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R454transgene spread, for instance by
restricting them locally or by removing
them once they are no longer needed
due to resistance development [7]. In a
recent study [8] published in Current
Biology, the group of Bruce Hay has
established a novel synthetic gene
drive mechanism for local application
and potential reversibility in Drosophila
melanogaster.
The first biotechnologically
engineered designer mosquitoes to
fight the Dengue vector Aedes aegypti
have already been released in small
scale trials in the Grand Cayman
Islands [9], Malaysia, and are
currently released in Brazil [10]. The
present control effort is based on a
very successful genetic pestmanagement strategy, termed ‘sterile
insect technique’ (SIT). SIT has proven
to prevent, control, suppress, or even
eradicate invasive insect pest
species — such as the Mediterranean
Fruit Fly, the New World Screw Worm,
or the Tsetse Fly — from islands,
large agricultural production areas, or
even complete continents [11]. SIT is
essentially an insect birth control
measure that involves mass
production of the pest insects, their
sterilization and sustained release of
large quantities of sterilized insects
over wide areas. When sterile
insects mate with the native
population, the unproductive matings
shrink the population. Due to its
species-specificity, SIT is considered
an environmentally friendly pest
management measure [12]. To use SIT
for mosquito control, there are three
features that insect transgenesis could
improve on [13]: first, in mosquitoes
only males can be released as even
sterile females would blood-feed and
could increase disease transmission
rates. Transgenic female-specific
lethality systems address this problem
and could support efficient genetic
sexing and subsequent male-only
releases [14]. Second, conventional
sterilization is carried out by irradiation
that reduces at the same time the
competitive fitness of released males.
In this respect, transgenic systems that
cause lethality after transmission to the
progeny could provide reproductive
sterility without fitness costs [15].
Third, transgenic marker systems
will enable discrimination of released
and naturally occurring insects,
helping to monitor the efficacy of SIT
applications, which is important in
order to release the right amount of
sterile insects for effective control while
keeping costs down [13].
Reproductive sterility based on
lethality systems serves as an
intrinsic containment against
vertical transmission of transgenes in
biotechnologically engineered SIT and
its application does, therefore, not
present real concerns with respect to
humans or the environment [13].
However, transgenic SIT is still at its
very beginnings and its large scale
use may be somewhat premature,
especially as it might impinge on the
future use of this technology due to
possible development of resistance
[16]. Despite the fact that SIT
approaches have shown to be very
successful for agricultural insectpests [11] and will probably be useful
also to control human disease vectors,
the insect in the transmission of
vector-borne diseases is only annoying
but not the cause of the illness itself.
Therefore, replacement strategies have
been considered that would not
suppress or eradicate the insect
vector but instead make it refractory
to the transmission of the disease —
causing pathogens [3]. To locally
restrict the spread of or actually
recall the refractoriness providing
transgenes, the group of Bruce Hay
has successfully tested a controllable
synthetic gene drive mechanism based
on the principle of underdominance
using an artificial MEDEA (maternal
effect dominant embryonic arrest)
system in the insect model Drosophila
melanogaster [8].
Maternal-effect selfish genes were
first described in the red flour beetle
Tribolium castaneum and called
MEDEA [17] — a fitting acronym as in
Greek mythology Medea killed her
kids sired by the ‘wrong’ man, Jason,
after he rejected her. Tribolium
Medea elements are based on a still
hypothetical maternal lethal activity
that kills all progeny not bearing the
correct Medea allele [18]. As this
‘selfish’ mechanism ensures that
progeny of carrier mothers only survive
when they inherit from either parent a
copy of this genetic element, the
inheritance is non-Mendelian
(Figure 1A) and leads to a population
spread of the genetic element. Based
on this concept, a synthetic MEDEA
system was designed in Drosophila
[19] using maternally expressed
microRNAs against a maternally
provided mRNA that is necessary for
embryo survival. The zygotic rescue
activity in this synthetic system is
due to a transgene from which the
respective mRNA is transcribed
and which is insensitive to the
microRNAs (Figure 1B). This system
drives population replacement by
spreading itself in a non-Mendelian
but uncontrollable manner [19]. Hay
and colleagues [8] have further
developed this synthetic system into
double-MEDEA (Figure 2A) to get
control over the transgene spread by
under- or overdominance.
Underdominance (heterozygote
inferiority) means that the fitness of
both homozygous genotypes is higher
than of the heterozygous genotype
[20]. Over time, this leads to disruptive
selection towards either of the two
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Figure 2. Gene drive by double-MEDEA systems.
(A) Double-MEDEA system [8], in which one transgene pair produces one maternal toxin (A)
and the zygotic antidote (AntiB) for another maternal toxin (B) produced by a second
transgene pair that also produces the zygotic antidote for the first toxin (AntiA). (B) In
a single locus double-MEDEA system the two reciprocal maternal toxin–zygotic antidote
transgene pairs are placed at the same position of homologous chromosomes. In this
situation only the 50% trans-heterozygote progeny survives, while the homozygotes die
(red X), as they miss one antidote [8]. In this scenario the homozygotes are at a disadvantage,
which actually resembles a genetic overdominance system (heterozygote superiority). (C) In
a two loci double-MEDEA system, the two reciprocal maternal toxin–zygotic antidote
transgene pairs are placed at different positions in the genome (e.g. on different
chromosomes). When the mother carries both transgene pairs and thus produces both toxins,
both gene loci need to be inherited by the progeny for survival. This leads to an
underdominance effect (heterozygote inferiority), since only 56% of progeny of a double het-
erozygote cross (middle) will survive, while 100% progeny of a wild type (left side) or a double
homozygote cross (right side) will survive [8]. For the ‘drive in’ with the maternal toxin–zygotic
antidote MEDEA system actually only males carrying the transgenes are necessary. However,
to ‘drive out’ the MEDEA system again also females would have to be released in large
numbers [8].
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depending on the respective allele
frequency. Underdominance systems
are therefore preferential for local
replacements with limited spread
due to the high number of insects
that would need to be released [6].
To generate underdominance, Hay
and colleagues [8] use a two gene
loci double-MEDEA system that is
composed of two reciprocal maternal
toxin–zygotic antidote transgene pairs
that are placed at different positions
in the genome (Figure 2A). When both
transgene pairs are carried by the
mother and thus both toxins are
produced, both gene loci need to be
inherited by the progeny for survival.
Thus, all progeny of a wild type or a
double homozygote cross but only
about half of the progeny of a double
heterozygote cross will survive,
causing an underdominance effect
(Figure 2C) that serves as an unstable
bottleneck that will ultimately lead to
divergent genotypes: either towards
wild type or towards homozygous
double transgenics depending on the
initial number of wild-type or transgene
carrying alleles of the gene loci,
respectively [8]. Therefore, the
underdominance effect can be used
as a switch to either replace animals
in a local population with transgene
carriers (drive in, replacement) or to
replace transgene carriers with
wild-type animals (drive out, transgene
recall, reversion) [8]. Transgenic
underdominance systems are usually
difficult to generate, because first
inferior transgenic heterozygotes
have to be generated. The synthetic
maternal toxin–zygotic antidote
MEDEA system has, however, the
advantage that the transgenes can
be introduced via the males that
show — due to the lack of maternal
toxicity — normal Mendelian
inheritance. Moreover, only males are
necessary to actually inundate the
wild-type population in order to
spread the transgene combinations
(Figure 2C). This is especially important
for mosquito releases, because the
release of female mosquitoes, which
feed on humans, might actually
increase temporarily the transmission
of vector-borne diseases. This actually
is also the drawback of the described
two loci underdominance system in
respect to transgene recall [8], as this
requires the release of large quantities
of females, which is probably not
tolerable in a disease-threatened area.Hay and colleagues [8] also describe
a single locus double-MEDEA system
that acts as a genetic overdominance
(heterozygote superiority) system [20],
in which both homozygous genotypes
have a lower fitness than the
heterozygous genotype (Figure 2B).
One disadvantage of the single locus
system is that only half of the progeny
survive, which might hamper mass
rearing. Also the single locus system
can be introduced into a population
via male-only releases, which requires,
however, a very high release ratioor releases over two consecutive
generations [8]. This would serve as
a local confinement factor for
populations with moderate migration
rates [7]. Moreover, the single locus
system has two other advantages: first,
the release of wild-type males into an
established transgenic (heterozygous)
population causes a dramatic
population decline, which could be
used as a mosquito control measure
similar to SIT in addition to the
refractoriness to disease transmission.
Second, after such an induced
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R456population decline only few males and
females would have to be released to
actually recall the transgenes and
revert the mosquito population to wild
type (drive out, reversion).
So far these systems have only been
described in the non-pest insect model
organism Drosophila [8], and it will take
its time until similar strategies will have
been successfully developed for
human disease vectors. In addition, it
will take enormous efforts by
international regulators in collaboration
with molecular entomologists,
ecologists, and operational pest
managers to develop clear regulatory
frameworks for the safe release of
such beneficial transgenic insects.
Nevertheless, the principal concepts to
establish transgenic refractoriness to
malaria or dengue transmission in
mosquitoes as well as to control a
locally refined spread and to recall the
transgenes are established, which
nurtures the long-standing hope that
insect transgenesis can indeed be
employed for novel strategies to fight
human vector-borne diseases.
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E-mail: ewimmer@gwdg.dehttp://dx.doi.org/10.1016/j.cub.2013.03.058Chromatin: A Tail of RepressionGenetic evidence on the role of specific histone amino acids or their
posttranslational modifications in metazoan development has been lacking.
A recent study reports that fruit flies carrying histone H3 lysine 27 (H3K27)
mutations have the same homeotic gene expression and developmental
defects as mutations in the enzyme that trimethylates H3K27.Danesh Moazed
The four canonical histones, H2A,
H2B, H3, and H4, are among the most
highly conserved eukaryotic proteins.
Between cow and pea, all but 2 of the
103 amino acids in histone H4 are the
same, and there are only 8 amino acid
differences between the yeast and
human H4 proteins. Histones package
DNA into chromatin and in keeping
with their extraordinary conservation
play important roles in nearly
all DNA transactions. That the
post-translational modifications of
histones play a central role in theregulation of chromatin structure and
transcription is a basic tenant of current
models of gene regulation. It may
come as a surprise to many that
in multicellular eukaryotes a direct
demonstration of a role for a specific
histone amino acid, or its modification,
in gene activation or silencing was
lacking until recently. In a paper
published in Science last month [1],
Muller, Herzig and colleagues now
remedy this situation by demonstrating
that a point mutation in lysine 27 of
histone H3 (H3K27) fails to silence
genes that are targeted by the
Polycomb Repressive Complex 2(PRC2), the methyltransferase that
modifies H3K27.
The basic unit of chromatin is the
nucleosome, which contains 147 base
pairs of DNA wrapped twice around
an octamer composed of four histones
[2]. Histones contain a variety of
posttranslational modifications,
which are mostly but not exclusively
concentrated on their amino termini.
These modifications provide binding
sites for proteins that mediate
downstream functions, ranging
from activation and repression of
transcription to coordination of DNA
damage repair. In addition, they affect
the interaction of the positively charged
histone tails with DNA, thereby
regulating nucleosome stability [3]. In
Drosophila, mammals, and many other
multicellular organisms, the stable
silencing of developmental regulators,
such as the homeotic master
regulators, outside of their proper
